Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AC DENTAL LABORATORIUM ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   6.4% 7.5% 7.0% 7.4% 4.8% 14.2% 20.6% 20.4%   Credit score (0-100)   39 34 36 34 45 14 4 4   Credit rating   BBB BB BBB BB BBB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   441 383 457 523 738 544 0.0 0.0   EBITDA   -17.7 -61.4 0.8 60.2 169 -154 0.0 0.0   EBIT   -17.7 -71.1 -8.9 50.5 159 -164 0.0 0.0   Pre-tax profit (PTP)   -19.3 -75.2 -14.0 44.5 152.7 -166.0 0.0 0.0   Net earnings   -19.3 -75.2 -14.0 44.5 152.7 -166.0 0.0 0.0   Pre-tax profit without non-rec. items   -19.3 -75.2 -14.0 44.5 153 -166 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022e N/A 2023e N/A Tangible assets total   0.0 38.8 29.1 19.4 9.7 0.0 0.0 0.0   Shareholders equity total   165 50.8 36.8 81.3 234 11.5 -114 -114   Interest-bearing liabilities   55.4 101 122 123 129 140 114 114   Balance sheet total (assets)   248 178 193 240 417 184 0.0 0.0   Net Debt   -41.3 65.7 33.5 29.6 -112 -37.0 114 114     See the entire balance sheet 1000.0 Volume  2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   441 383 457 523 738 544 0.0 0.0   Gross profit growth   0.0% -13.0% 19.3% 14.3% 41.1% -26.2% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   248 178 193 240 417 184 0 0   Balance sheet change%   0.0% -28.4% 8.5% 24.5% 73.8% -55.8% -100.0% 0.0%   Added value   -17.7 -71.1 -8.9 50.5 159.0 -163.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 29 -19 -19 -19 -19 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -4.0% -18.6% -2.0% 9.7% 21.6% -30.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -7.1% -33.4% -4.8% 23.3% 48.4% -54.4% 0.0% 0.0%   ROI %   -8.0% -38.2% -5.7% 27.8% 56.0% -63.6% 0.0% 0.0%   ROE %   -11.7% -69.7% -32.0% 75.4% 96.8% -135.2% 0.0% 0.0%   1000.0 Solidity  2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022e N/A 2023e N/A Equity ratio %   66.5% 28.6% 19.1% 33.9% 56.1% 6.2% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   233.5% -107.0% 4,368.2% 49.2% -66.4% 24.0% 0.0% 0.0%   Gearing %   33.6% 198.7% 332.7% 151.5% 55.1% 1,217.9% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.0% 5.2% 4.6% 4.8% 5.0% 1.7% 0.0% 0.0%   1000.0 Liquidity  2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022e N/A 2023e N/A Quick Ratio   2.1 1.0 1.0 1.3 2.1 1.1 0.0 0.0   Current Ratio   2.3 1.1 1.0 1.4 2.2 1.1 0.0 0.0   Cash and cash equivalent   96.7 35.2 88.9 93.6 240.8 177.1 0.0 0.0   1000.0 Capital use efficiency  2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   104.6 12.1 7.7 62.0 224.3 11.5 -57.2 -57.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -18 -71 -9 50 159 -164 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -18 -61 1 60 169 -154 0 0   EBIT / employee   -18 -71 -9 50 159 -164 0 0   Net earnings / employee   -19 -75 -14 45 153 -166 0 0